Abstract
Objective To investigate the clinical efficacy of combined use of calcineurin inhibitor in the treatment of lupus nephritis in induction or maintenance, which is resistant to mycophenolate mofetil. Methods Sixty-six cases of children with lupus nephritis were selected from February 2014 to September 2016 in Huazhong University of Science and Technology, Tongji Medical College Affiliated Wuhan Children′s Hospital.The randomized method was used to divide them into the control group and the observation group randomly.Among them, 31 cases in the control group were given glucocorticoid, cyclophosphamide combined with traditional medicine for treatment; 35 cases in observation group were given glucocorticoid, mycophenolate mofetil, tacrolimus (calcine phosphatase inhibitor) multi-target therapy for treatment.The clinical effect of 2 groups before and after treatment were compared, and the incidence of adverse reactions in the treatment of 2 groups of children were compared. Results After treatment, the levels of systemic lupus erythematosus disease activity index(SLEDAI), serum creatinine and 24 h urine protein [(6.05±1.04) scores, (45.08±18.52) μmol/L, (0.96±0.30) g/L] in the observation group were lower than those in the control group [(11.09±2.33) scores, (95.33±36.74) μmol/L, (2.05±0.74) g/L], and the differences were statistically significant (t=3.097, 3.356, 3.871, all P<0.05). Serum complement C3, plasma albumin levels[(1.05±0.28) g/L, (63.24±12.98) g/L] were higher than those in the control group [(0.34±0.10) g/L, (35.45±6.74) g/L], and the differences were statistically significant (t=4.124, 3.567, all P<0.05). After treatment, the levels of serum complement C3 and plasma albumin were significantly higher between 2 groups than those before treatment, the differences were statistically significant (all P<0.05). The incidence of adverse reaction (14.29%, 5/35 cases) in the observation group was lower than that in the control group (38.71%, 12/31 cases), and the difference was statistically significant (χ2=5.128, P<0.05). Conclusion Multi-target combination therapy and traditional cyclophosphamide therapy can effectively control lupus nephritis in children, but the clinical effect of multi-target combination therapy is better and the adverse reaction is less. Key words: Calcineurin inhibitor; Lupus nephritis; Induction period; Maintenance period; Clinical efficacy
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
